Colourful i-Base graphic. The main text reads: Gilead sets sky-high price for lenacapavir PrEP. Cheaper to become HIV positive. At the top is i-Base’s website address: I hyphen base dot info. At the bottom it says, subscribe by email. A smaller, tilted square graphic on the right, reads: HTB news. 2025. HIV treatment, prevention, access, and more. The colours used in the image are two shades of yellow, green, plum, teal, dark blue, light blue, orange, mustard, red, and white.
Long-acting #injectablePrEP approved in the US – at $28,000 a year, despite modelling showing generic price could be just $25 per person:
i-base.info/htb/51357
It would be cheaper to become #HIVpositive and take ART than use #Yeztugo #lenacapavir as #PrEP.
#HIVsky #HIV #HIVprevention #Gilead